# Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids

> **NCT04821219** · NA · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Pancreas Adenocarcinoma

## Interventions

- **OTHER:** Treatment prediction PDT platform

## Key facts

- **NCT ID:** NCT04821219
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study PI no longer at Institution
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821219, "Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04821219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*